Insider filing · ARWR
William D. Waddill
Director
profile →
Arrowhead Pharmaceuticals, Inc.
ARWR · Healthcare · 34 filings in 24 months
ticker →
William D. Waddill sold $532K of Arrowhead Pharmaceuticals (ARWR)
Executed Dec 19 2025, disclosed Dec 23 2025, 4 days later.
Value, as filed
$532K
7,867 sh across 2 lots
Executed
Dec 19 2025
the trade date, as filed
Disclosed
Dec 23 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
WWWilliam D. Waddill (Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Protagonist Therapeutics, Inc. (PTGX). The largest single filing was $1.7M of PTGX (20,000 sh × $83.68, as filed), executed Feb 6.
The name
ARWRHealthcare · Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→